Loading...

High Tide Inc.

2LYA.FXETRA
Healthcare
Medical - Pharmaceuticals
1.88
-0.01(-0.74%)

High Tide Inc. (2LYA.F) Financial Performance & Income Statement Overview

Review High Tide Inc. (2LYA.F) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
7.10%
7.10%
Operating Income Growth
112.08%
112.08%
Net Income Growth
88.97%
88.97%
Operating Cash Flow Growth
72.04%
72.04%
Operating Margin
0.22%
0.22%
Gross Margin
25.83%
25.83%
Net Profit Margin
-1.76%
1.76%
ROE
-6.78%
6.78%
ROIC
0.66%
0.66%

High Tide Inc. (2LYA.F) Income Statement & Financial Overview

Explore comprehensive income reports for High Tide Inc. 2LYA.F, broken down by year and quarter.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$142.46M$138.29M$131.69M$124.26M
Cost of Revenue$107.02M$102.54M$96.23M$112.44M
Gross Profit$35.44M$35.76M$35.45M$11.82M
Gross Profit Ratio$0.25$0.26$0.27$0.10
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$28.04M$26.62M$25.29M$8.71M
Operating Expenses$35.37M$38.59M$32.40M$8.71M
Total Costs & Expenses$142.39M$141.13M$128.63M$121.15M
Interest Income-$716000.00$0.00$0.00$0.00
Interest Expense$3.50M$3.95M$3.11M$2.83M
Depreciation & Amortization$5.85M$5.36M$5.68M$7.50M
EBITDA$6.70M$4.36M$10.29M$10.61M
EBITDA Ratio$0.05$0.03$0.08$0.09
Operating Income$67000.00-$2.83M$3.06M$3.11M
Operating Income Ratio$0.00-$0.02$0.02$0.03
Other Income/Expenses (Net)-$2.72M-$2.12M-$1.56M-$2.69M
Income Before Tax-$2.65M-$4.96M$1.50M-$707000.00
Income Before Tax Ratio-$0.02-$0.04$0.01-$0.006
Income Tax Expense$38000.00-$153000.00$671000.00-$878000.00
Net Income-$2.81M-$4.69M$717000.00-$25000.00
Net Income Ratio-$0.02-$0.03$0.005-$0.00
EPS-$0.03-$0.06$0.009-$0.00
Diluted EPS-$0.03-$0.06$0.009-$0.00
Weighted Avg Shares Outstanding$80.87M$80.79M$80.39M$78.98M
Weighted Avg Shares Outstanding (Diluted)$80.87M$80.79M$81.10M$78.98M

The company's financials show resilient growth, with revenue advancing from $124.26M in Q2 2024 to $142.46M in Q1 2025. Gross profit remained healthy with margins at 25% in Q1 2025 compared to 10% in Q2 2024. Operating income hit $67000.00 last quarter, sustaining a consistent N/A margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $6.70M. Net income rose to -$2.81M, while earnings per share reached -$0.03. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;